[1] Abrahams BS,Geschwind DH.Advances in autism genetics:on the threshold of a new neurobiology[J].Nat Rev Genet,2008,9(5):341-355. [2] Rutter M,Bailey A,Bolton P,et al.Autism and known medical conditions:myth and substance[J].J Child Psychol Psychiatry,1994,35(2):311-322. [3] Pampols T.Inherited metabolic rare disease[J].Adv Exp Med Biol,2010,686(3):397-431. [4] Ververi A,Vargiami E,Papadopoulou V,et al.Clinical and laboratory data in a sample of Greek children with autism spectrum disorders[J].J Autism Dev Disord,2012,42(7):1470-1476. [5] Dykens EM,Volkmar FR.Medical conditions associated with autism.In:Cohen DJ,Volkmar FR,eds.Handbook of Autism and Pervasive Developmental Disorders [M].New York:Wiley,1997. [6] Zecavati N,Spence SJ.Neurometabolic disorders and dysfunction in autism spectrum disorders[J].Curr Neurol Neurosci Rep,2009,9(2):129-136. [7] 顾学范,韩连书,高晓岚,等.串联质谱技术在遗传性代谢病高危儿童筛查中的初步应用[J].中华儿科杂志,2004,42(6):401-404. [8] Schulze A,Lindner M,Kohlmüller D,et al.Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry:results,outcome,and implications[J].Pediatrics,2003,111(6 Pt 1):1399-1406. [9] Frazier DM,Millington DS,McCandless SE,et al.The tandem mass spectrometry newborn screening experience in North Carolina:1997-2005[J].J Inherit Metab Dis,2006,29(1):76-85. [10] Steiner CE,Acosta AX,Guerreiro MM,et al.Genotype and natural history in unrelated individuals with phenylketonuria and autistic behavior[J].Arq Neuropsiquiatr,2007,65(2A):202-205. [11] Balieli S,Pavone L,Meli C,et al.Autism and phenylketonuria[J].J Autism Dev Disorders,2003,33(2):201-204. [12] Reiss AL,Feinstein C,Rosenbaum KN.Autism and genetic disorders[J].Schizophr Bull,1986,12(4):724-738. [13] Gillberg C,Coleman M.The Biology of the Autistic Syndromes[M].3rd ed,London:McKeith Press,2000. [14] Scheicht D,Werthmann ML,Zeglam S,et al.Muscle weakness and early stages of liver failure in a 22-year-old man[J].Internist (Berl),2013,54(8):1016-1122. |